Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1245813.RAXCTk18za66tHsZjkSh-DvJonTqv5WeakH6-Gkx4frGI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1245813.RAXCTk18za66tHsZjkSh-DvJonTqv5WeakH6-Gkx4frGI130_assertion type Assertion NP1245813.RAXCTk18za66tHsZjkSh-DvJonTqv5WeakH6-Gkx4frGI130_head.
- NP1245813.RAXCTk18za66tHsZjkSh-DvJonTqv5WeakH6-Gkx4frGI130_assertion description "[Of note, 40% of people with HNF1A-MODY and medical treatment were receiving insulin alone and thus were not being treated in line with up-to-date International Society for Pediatric and Adolescent Diabetes/International Diabetes Federation guidelines, despite insulin treatment being associated with worse metabolic control and the risk of hypoglycaemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1245813.RAXCTk18za66tHsZjkSh-DvJonTqv5WeakH6-Gkx4frGI130_provenance.
- NP1245813.RAXCTk18za66tHsZjkSh-DvJonTqv5WeakH6-Gkx4frGI130_assertion evidence source_evidence_literature NP1245813.RAXCTk18za66tHsZjkSh-DvJonTqv5WeakH6-Gkx4frGI130_provenance.
- NP1245813.RAXCTk18za66tHsZjkSh-DvJonTqv5WeakH6-Gkx4frGI130_assertion SIO_000772 25483937 NP1245813.RAXCTk18za66tHsZjkSh-DvJonTqv5WeakH6-Gkx4frGI130_provenance.
- NP1245813.RAXCTk18za66tHsZjkSh-DvJonTqv5WeakH6-Gkx4frGI130_assertion wasDerivedFrom befree-2016 NP1245813.RAXCTk18za66tHsZjkSh-DvJonTqv5WeakH6-Gkx4frGI130_provenance.
- NP1245813.RAXCTk18za66tHsZjkSh-DvJonTqv5WeakH6-Gkx4frGI130_assertion wasGeneratedBy ECO_0000203 NP1245813.RAXCTk18za66tHsZjkSh-DvJonTqv5WeakH6-Gkx4frGI130_provenance.